Symbioteq Kvalitet AB and Key2Compliance AB have become one company. The joint company is called Key2Compliance\u00ae and is a company within the Symbioteq group. The parent company is called Symbioteq Holding AB<\/p>\n
Another novelty is that in addition to Regulatory Affairs, Quality Assurance, Biological Evaluations and Toxicology, and Training we now also offer Clinical Development for companies working with medical devices. During the transition from MDD to MDR, more companies than before will need extended knowledge in clinical development. Usually, medical device companies have turned to traditional Pharma-CROs that are not specialists in clinical strategy for medical devices. Key2Compliance\u00ae can assist with a GAP analysis, a regulatory and clinical strategy and now also the implementation of clinical evaluations both locally and globally.<\/p>\n
Thus, if you are a medical device company, Key2Compliance\u00ae will be the only partner you need to meet all your regulatory challenges. Key2Compliance\u00ae will continue to offer complete and tailor-made training and courses solutions for both Pharma and Medical Device Companies.<\/p>\n
We are passionate about making complex things easier and helping you to a faster and smoother product development process.<\/p>\n
Let us guide you on your journey of development, from idea to market.
\nYou can rely on us.<\/p>\n","protected":false},"excerpt":{"rendered":"
Symbioteq Holding AB has acquired Key2Compliance AB and formed a new Company under the joint name Key2Compliance\u00ae Symbioteq Kvalitet AB and Key2Compliance AB have become one company. The joint company is called Key2Compliance\u00ae and is a company within the Symbioteq group. The parent company is called Symbioteq Holding AB Another novelty is that in addition […]<\/p>\n","protected":false},"author":3,"featured_media":65288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wds_primary_category":21,"footnotes":""},"categories":[21],"tags":[],"blog-subject":[],"class_list":["post-65471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/posts\/65471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/comments?post=65471"}],"version-history":[{"count":0,"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/posts\/65471\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/media\/65288"}],"wp:attachment":[{"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/media?parent=65471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/categories?post=65471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/tags?post=65471"},{"taxonomy":"blog-subject","embeddable":true,"href":"https:\/\/lightweb.dev\/s\/key2compliance\/wp-json\/wp\/v2\/blog-subject?post=65471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}